Zdrowie i gospodarka · 22/11/2023

FDA to Host Public Meeting on Advancing Drug Development for Spontaneous Preterm Birth Prevention

The FDA is hosting a public meeting to gather input from various stakeholders on advancing drug development for preventing spontaneous preterm birth, a topic led by Duke University's Dr. Robert J. Margolis. The meeting aims to discuss the impact of preterm birth on families and society, as well as the ethical, regulatory, and clinical trial considerations.